Alnylam Pharmaceuticals (ALNY) PT Raised to $190 at Chardan Capital Markets
Tweet Send to a Friend
Chardan Capital Markets analyst Keay Nakae raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $190.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
